Abstract Angelman syndrome (AS) is characterized by severe mental retardation, absent speech, puppet-like movements, inappropriate laughter, epilepsy, and abnormal electroencephalogram. The majority of AS patients (= 65%) have a maternal deficiency within chromosomal region 15qll-q13, caused by maternal deletion or paternal uniparental disomy (UPD). Approximately 35% of AS patients exhibit neither detectable deletion nor UPD, but a subset of these patients have abnormal methylation at several loci in the 15ql l-q13 interval. We describe here three patients with Angelman syndrome belonging to an extended inbred family. High resolution chromosome analysis combined with DNA analysis using 14 marker loci from the 15ql l-q13 region failed to detect a deletion in any of the three patients. Paternal UPD of chromosome 15 was detected in one case, while the other two patients have abnormal methylation at D15S9, D15S63, and SNRPN. Although the three patients are distantly related, the chromosome 15ql 1-q13 haplotypes are different, suggesting that independent mutations gave rise to AS in this family.
Introduction
paroxysms of laughter, a puppet-like ataxic gait, microcephaly, and epilepsy (Witlems et al. 1987; Williams et al. 1989; . The incidence of AS has been estimated to be around 1/20000 (ClaytonSmith and Pembrey 1992) . In about 65% of AS patients, an interstitial deletion within 15ql 1~-113 or paternal uniparental disomy of chromosome 15 can be detected by cytogenetic and/or molecular methods (Hamabe et al. 1991 b; Malcolm et al. 1991; Beuten et al. 1993) . The deletions are found exclusively on the maternal chromosome. Prader-Willi syndrome (PWS), a phenotype distinct from AS, results from paternal-specific deficiency in 15ql lq13, caused most frequently (in 70% of the patients) by deletion (Butler 1990; Robinson et al. 1991; Nicholls 1993) . Most of the remaining 30% of PWS patients are found to have matemal uniparental disomy (UPD), however, paternal UPD is rare in AS.
Alternative genetic mechanisms have been proposed to explain the occurrence of AS in the remaining cases where neither a deletion nor UPD could be detected. Linkage analysis in the families with multiple AS patients reported by Wagstaff et al. (1993) and Meijers-Heijboer et al. (1993) yielded positive lod scores, indicating linkage of AS to a locus in the 15ql 1-q13 region. Pedigree analysis and linkage analysis of these families indicate autosomal dominant inheritance of AS modified by genomic imprinting, such that AS is expressed when the mutation is inherited maternally, but the mutation is asymptomatic when transmitted paternally Wagstaff et al. 1993; Meijers-Heijboer et al. 1993; Nelen et al. 1994) . A tk)urth class of AS patients is characterized by absence of the classical deletion and UPD, but with an abnormal methylation pattern of some 15qllmql3 loci. AS in these patients has been proposed to result from mutations in a proximal 15q imprinting region (imprinting mutations) (Glenn et al. 1993a; Horsthemke et al. 1994; Reis et al. 1994a, b; Sutcliffe et al. 1994) . Recently, small deletions between D15S63 and SNRPN (the small nuclear ribonucleoprotein locus) have been identified in some of these patients, suggesting that the imprinting mutation is caused by deletion of an imprinting region in 15ql 1~113 (Buiting et al. 1995) .
We report here three AS patients belonging to an extended, highly inbred, Dutch family. Cytogenetic and molecular analysis failed to reveal deletion in any of the three patients. One case demonstrated paternal isodisomy of chromosome 15, and the two other cases showed an abnormal methylation pattern of three different loci in the AS region.
Materials and methods

Patients
The three AS patients studied in this report were diagnosed by an experienced clinical geneticist (R.C.M.H.). The pedigree (Fig. 1 A) reveals a significant inbreeding and all of the parents of the three probands are descended from three ancestral couples. As the surnames of two pairs of these ancestors (I1/13 and I2/I4) are the same, further consanguinity may well be present. The clinical criteria for diagnosis were: severe mental retardation, (nearly) absent II   III   IV   V   VI   VII   VIII   295 speech, ataxia, hyperactivity, bursts of laughter, brachycephaly, macrostomia, and prognatism ( Fig. 1 B) . Seizures were present in two patients, and characteristic electroencephalogram changes in all three. Terminal deletion of chromosome 16p, a condition with some similar clinical features and thalassemia, was excluded by hemoglobin analysis (Wilkie et al. 1990 ).
Cytogenetic and molecular studies
High-resolution chromosome analysis was performed using Giemsa-trypsin banding on peripheral blood lymphocytes of the three AS patients, with special attention paid to chromosome 15.
Genomic DNA of the patients and their parents was extracted either directly from peripheral blood leukocytes or from EpsteinBarr virustransformed lymphoblastoid cells. Southern blot analysis was performed according to standard procedures. The following chromosome 15q 11 ~t 13 DNA probes recognizing restriction fragment length polymorphisms (RFLPs) were used for deletion analysis: plR4-3R/D15Sll, pTD189-1/D15SI3, pTD3-21/D15SIO, 28 §3-H3/GABRB3, pIR10-1/D15Sl2, pCMW-1/D15S24, and the telomeric marker cMS620/D15S86. Polymerase chain reaction (PCR) amplification was performed for dinucleotide repeats at DI5SIO (Lindeman et al. 1991) , D15Sll, D15S113, GABRB3 (the y-aminobutyric acid I] receptor locus, Mutirangura et al. 1993 a) , D15S13 (Mutirangura et al. 1993 b) , D15S63 (Wagstaff et al. 1993) , D15S97, D15S122, D15S128, D15S156 (Beckmann et al. 1993) , DI5S229E (Sutcliffe et al. 1994) , and D15S210 (Gyapay et al. 1994 ).
Methylation analysis DNA isolated from peripheral blood leukocytes was digested with a combination of conventional and methylation-sensitive restriction enzymes, separated in a 0.8% agarose gel, and analyzed by Southern blot hybridization using probes pML34, PW71 or exon c~ of SNRPN. For both pML34 (B. Horsthemke, personal communication) and PW71 (Dittrich et al. 1992 ) a combination of the enzymes HindlII and HpalI was used, and a double digestion with XbaI and NotI was used for the analysis of the SNRPN CpG island (Sutcliffe et al. 1994; Beuten et al. 1995) . Fig. 1 A Pedigree of the family analyzed in this study. The parents of patient VIII-3, VIII-5, and VIII-9 all originate from three ancestral couples. The stippled lines in generation I indicate that these couples were probably related as they carry the same family names. B Photographs of the three patients VIII-3, VIII-5, and VIII-9
Results and discussion
We have studied three distantly related patients of an extended inbred family of Dutch ancestry that all fulfill the clinical criteria for AS (Fig. 1 ). Cytogenetic studies with high resolution chromosome banding showed a normal chromosome 15 pattern in all three patients (data not shown). DNA analysis with 19 markers recognizing 14 loci within 15qll-q13 was performed for the three AS patients and their parents. Figure 2 shows the presence of two different alleles in patients VIII-5 and VIII-9 at the GABRB3 locus. The haplotypes of the three AS patients for the 15q 11-q 13 loci are presented in Fig. 3 . No deletions were detected using the seven RFLP markers and 12 polymorphic dinucleotide repeats. Patient VIII-3 demonstrated homozygosity of all markers studied on chromosome 15, including the telomeric marker cMS620, suggesting paternal UPD (Fig.4) . Ten AS patients with UPD have been reported, one with heterodisomy and the remaining nine cases, including our patient, with isodisomy. The etiology of UPD has been suggested to be maternal nondisjunction during maternal meiosis both for AS and PWS (Mutirangura et al. 1993a ). The occurrence of maternal nondisjunction is generally associated with an increased maternal age. This has been found in PWS (Robinson et al. 1991; Mutirangura et al. 1993 a) and in AS (Mutirangura et al. 1993 a) . However, the mother of our AS patient with UPD was only 24 years at the time of birth. Although others have found some evidence for a milder phenotype in UPD patients (Bottani et al. 1994; Gillessen-Kaesbach et al. 1995) , the presently described patient with UPD was indistinguishable from deletion-positive AS patients. Approximately 65% of AS patients exhibit interstitial deletions within proximal 15q and a small minority of AS patients have paternal UPD. In a small subset of AS patients without the classical deletion or UPD, an abnormal methytation pattern within chromosome 15q11~113 at three different loci SNRPN (exon o0, D15S63 (PW71), and D15S9 (pML34) has been detected (Glenn et al. 1993 a; Reis et al. 1994a, b; Sutcliffe et al. 1994) . Driscoll et al. (1992) first described methylation differences in ZNF127 at D15S9. A methylation difference at D15S63 (detected with the PW71 probe) has been reported by Dittrich et al. (1992) . Glenn et al. (1993 b) and Sutcliffe et al. (1994) found a methylation pattern specific for the maternal homolog within the CpG island containing exon c~ of the SNRPN gene. Recently, it has been shown that at least some of these "imprinting mutations" are caused by small deletions proximal from SNRPN (Buiting et al. 1995) . Our two AS patients with apparently biparental inheritance of chromosome 15 (VIII-5 and VIII-9) demonstrated a methylation pattern typical of a paternal chromosome on their maternal chromosomes at loci exon a~ of SNRPN and D15S63 (PW71 probe). In normal individuals, a methylated maternal 4.2-kb fragment and an unmethylated paternal 0.9-kb fragment can be seen using SNRPN exon c~ hybridization with DNA digested with NotI and XbaI (Sutcliffe et al. 1994; Beuten et al. 1995) . Southern hybridization of DNA digested with HindlII and HpaII with PW71 (D15S63) reveals a 6.0-kb methylated maternal and a 4.4-kb unmethylated paternal allele in normal control samples (Dittrich et al. 1992) . For both exon ~ (Fig. 5) and PW71 a complete absence of the maternal fragment in the two AS patients with imprinting mutations was found. Their respective mothers showed a normal methylation pattern for exon ~ ( 2) , a paternal methylated 0.9-kb fragment in AS patients with a classical large deletion (lane 3). Lanes 5 and 7 are the AS patients with imprinting mutations and their respective mothers (lanes 6 and 8). The DNA from the patients and their mothers was extracted from Epstein-Barr virus-transformed lymphoblasts, whereas the other samples were extracted from peripheral lymphocytes sonal communication). Using pML34, we found an inconstant methylation pattern in both AS patients with equal or slightly reduced intensity of the maternal band. tt has been shown that the methylation of the maternal allele at D15S9 is not complete in AS patients (Dittrich et al. 1992; Driscoll et al. 1992) , in contrast to the complete methylation of the maternal homolog of exon c~ (SNRPN) and PW71 (D15S63) (Dittrich et al. 1992; Sutcliffe et al. 1994 ). These results correspond with previous reports describing PWS patients and AS patients with an abnormal methylation pattern both for exon ot and PW71, whereas D15S9 shows a normal methylation pattern (Glenn et al. 1993a; Buiting et al. 1994; Reis et al. 1994a ).
VII
There are different alternatives to explain the occurrence of three AS patients in this large inbred family. A first possibility is that two independent mutations (UPD in patient VIII-3 and an inherited methylation mutation in patients VIII-5 and VIII-9) occurred. An autosomal dominant methylation mutation (cis-acting on chromosome 15, or trans-acfing on another chromosome), was excluded by pedigree analysis, as inheritance both through maternal and paternal lines exists without phenotypic expression of AS or PWS. A cis-acting methylation mutation, both autosomal dominant as welt as autosomal recessive, could further be excluded by haplotype analysis showing different haplotypes for both imprinting mutation AS patients. It is possible, however, that an autosomat recessive trans-acting imprinting mutation segregates in this family. Alternatively, it is possible that three independent mutations are responsible for AS: UPD in patient VIII-3 and two independent cis-acting chromosome 15 imprinting mutations in patients VIII-5 and VIII-9.
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